These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 14671028

  • 41. The application of evidence-based principles of care in older persons (issue 2): management of lipid disorders.
    Zarowitz BJ, Aronow WS, Hollenack K, O'Shea T.
    J Am Med Dir Assoc; 2006 Mar; 7(3):173-9. PubMed ID: 16503311
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Statins and diabetic hyperlipidemia].
    Vergès B.
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 2):128-32. PubMed ID: 11240415
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Assessment and management of vascular disease risk in patients with chronic kidney disease.
    Brown WV, Bakris G, Lerma E, Chertow G.
    J Clin Lipidol; 2011 Feb; 5(4):251-60. PubMed ID: 21784369
    [No Abstract] [Full Text] [Related]

  • 48. [Dyslipidemia in renal failure].
    Fujioka T, Ueno T, Matsumoto T, Watanabe H.
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():118-23. PubMed ID: 15250280
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. (8) Cardiovascular disease and risk management.
    American Diabetes Association.
    Diabetes Care; 2015 Jan; 38 Suppl():S49-57. PubMed ID: 25537708
    [No Abstract] [Full Text] [Related]

  • 53. Reducing CVD risk.
    Aranjo C.
    Aust Fam Physician; 2008 Sep; 37(9):695. PubMed ID: 18837159
    [No Abstract] [Full Text] [Related]

  • 54. [A change of attitude in lipidology, achievement of target levels. What comes next?].
    Márk L, Dani G, Kiss Z, Katona A.
    Orv Hetil; 2008 Sep 14; 149(37):1731-6. PubMed ID: 18805756
    [Abstract] [Full Text] [Related]

  • 55. Diabetic dyslipidaemia: insights for optimizing patient management.
    Vergès B.
    Curr Med Res Opin; 2005 Sep 14; 21 Suppl 1():S29-40. PubMed ID: 15811197
    [Abstract] [Full Text] [Related]

  • 56. Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?
    Krause BR, Princen HM.
    Atherosclerosis; 1998 Sep 14; 140(1):15-24. PubMed ID: 9733211
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Hyperlipidaemia and cardiovascular disease.
    Stone NJ.
    Curr Opin Lipidol; 2001 Dec 14; 12(6):667-9. PubMed ID: 11801867
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.